Detalles de la búsqueda
1.
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.
Hepatol Res
; 52(7): 586-596, 2022 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-35352445
2.
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.
Hepatol Res
; 52(6): 508-521, 2022 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-35129841
3.
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.
Carcinogenesis
; 42(1): 58-69, 2021 02 11.
Artículo
Inglés
| MEDLINE | ID: mdl-32449510
4.
Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.
Hepatol Res
; 50(6): 715-725, 2020 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-32202371
5.
High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C.
Hepatol Res
; 50(6): 671-681, 2020 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-32020702
6.
Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.
Hepatol Res
; 49(11): 1275-1285, 2019 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-31261439
7.
Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.
Hepatol Res
; 49(10): 1207-1217, 2019 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-31219667
8.
Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis.
Hepatol Res
; 49(11): 1294-1304, 2019 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-31260579
9.
Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
Carcinogenesis
; 38(11): 1073-1083, 2017 10 26.
Artículo
Inglés
| MEDLINE | ID: mdl-28927233
10.
Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.
J Med Virol
; 89(5): 857-866, 2017 05.
Artículo
Inglés
| MEDLINE | ID: mdl-27664407
11.
Long-read direct RNA sequencing reveals epigenetic regulation of chimeric gene-transposon transcripts in Arabidopsis thaliana.
Nat Commun
; 14(1): 3248, 2023 06 05.
Artículo
Inglés
| MEDLINE | ID: mdl-37277361
12.
Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.
J Med Virol
; 82(12): 2064-72, 2010 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-20981794
13.
Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis.
Hepatol Res
; 45(11): 1152-4, 2015 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-25581267
14.
Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma.
JGH Open
; 4(5): 880-888, 2020 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-33102759
15.
Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting.
JGH Open
; 4(1): 54-60, 2020 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-32055698
16.
Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
J Med Virol
; 81(4): 619-27, 2009 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-19235854
17.
Magnitude of CD8 T-cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection.
Hepatol Res
; 39(3): 256-65, 2009 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-19054151
18.
Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three Cases.
Intern Med
; 58(6): 797-802, 2019 Mar 15.
Artículo
Inglés
| MEDLINE | ID: mdl-30449808
19.
The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment.
Intern Med
; 58(7): 943-947, 2019 Apr 01.
Artículo
Inglés
| MEDLINE | ID: mdl-30568153
20.
Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence.
Drug Des Devel Ther
; 12: 2749-2756, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-30233138